Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Caveolin-1 Antibody (7C8), Novus Biologicals™

Mouse Monoclonal Antibody has been used in 25 publications
Supplier: Novus Biologicals NB100615
Description
Caveolin-1 Monoclonal specifically detects Caveolin-1 in Human, Mouse, Rat, Sheep samples. It is validated for Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry/Immunofluorescence, Immunoprecipitation, Immunohistochemistry-Paraffin, Immunohistochemistry-Frozen, Immunoblotting.Specifications
Caveolin-1 | |
Monoclonal | |
1.25 mg/mL | |
Western Blot 1:1000-1:4000, Flow Cytometry 1 ug per million cells, Immunohistochemistry 1:100-1:300, Immunocytochemistry/Immunofluorescence 1:200, Immunoprecipitation 1-2 ug/ 500 ug of protein, Immunohistochemistry-Paraffin 1:100-1:300, Immunohistochemistry-Frozen reported in scientific literature (PMID 24758774), Immunoblotting reported in scientific literature (PMID 31759628) | |
CAV1 | |
Intracellular membrane protein-containing vesicles (containing GLUT4) from rat adipocytes | |
Protein A purified | |
RUO | |
Primary | |
This is specific for caveolin alpha and beta proteins. | |
Aliquot and store at -20C or -80C. Avoid freeze-thaw cycles. | |
IgG2b |
Western Blot, Flow Cytometry, Immunohistochemistry, Immunocytochemistry, Immunofluorescence, Immunoprecipitation, Immunohistochemistry (Paraffin), Immunohistochemistry (Frozen), Immunoblot | |
7C8 | |
Unconjugated | |
CAV, caveolae protein, 22kD, caveolin 1, caveolae protein, 22kDa, cell growth-inhibiting protein 32, MSTP085 | |
Mouse | |
23 kDa | |
0.1 mL | |
Cancer, Caveolae Markers, Cellular Markers, Cholesterol Metabolism, Hypoxia, Lipid and Metabolism, Lipid Droplets, Signal Transduction | |
857 | |
Human, Mouse, Rat, Sheep | |
Purified |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
For Research Use Only
Spot an opportunity for improvement?Share a Content Correction